Company Filing History:
1 out of 75 
1 out of 846 
Years Active: 2013
Title: Akihiko Hisaminato: Innovator in Nucleic Acid Research
Introduction
Akihiko Hisaminato is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of nucleic acids, particularly through his innovative research and patents. His work focuses on developing aptamers that can bind to β-NGF, which has implications for treating various diseases and disorders.
Latest Patents
Hisaminato holds a patent titled "Aptamers to β-NGF and their use in treating β-NGF mediated diseases and disorders." This patent relates to the development of aptamers capable of binding to β-NGF, along with pharmaceutical compositions that include these aptamers. The methods of making and using these aptamers are also detailed in the patent, showcasing Hisaminato's expertise in this specialized area.
Career Highlights
Throughout his career, Akihiko Hisaminato has worked with notable companies such as Somalogic, Incorporated and Otsuka Pharmaceutical Company, Limited. His experience in these organizations has allowed him to further his research and contribute to advancements in the medical field.
Collaborations
Hisaminato has collaborated with esteemed colleagues, including Daniel J Schneider and Sheela M Waugh. These partnerships have enriched his research endeavors and fostered innovation in his projects.
Conclusion
Akihiko Hisaminato is a distinguished inventor whose work in nucleic acids and aptamer technology has the potential to impact the treatment of β-NGF mediated diseases. His contributions to the field are noteworthy and reflect his dedication to advancing medical science.